SCHEMBL8307394

SCHEMBL8307394

Cn1ccnc1Sc1ccc(Nc2ncnc3ccc(OCCBr)cc23)cc1F

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
EGFR P00533 10/20 0.45
FBP1 P09467 1/20 0.44
HDAC3 O15379 4/20 0.44
HDAC4 P56524 4/20 0.44
HDAC1 Q13547 4/20 0.44
HDAC7 Q8WUI4 4/20 0.44
HDAC2 Q92769 4/20 0.44
HDAC10 Q969S8 4/20 0.44
HDAC11 Q96DB2 4/20 0.44
HDAC8 Q9BY41 4/20 0.44
HDAC6 Q9UBN7 4/20 0.44
HDAC9 Q9UKV0 4/20 0.44
HDAC5 Q9UQL6 4/20 0.44
ERBB2 P04626 5/20 0.43
MAPT P10636 2/20 0.41
GRM1 Q13255 1/20 0.41
GCK P35557 3/20 0.40
RIPK2 O43353 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8307493 0.91 EGFR (0.46) EGFRFBP1HDAC3HDAC4HDAC1
SCHEMBL8449810 0.85 EGFR (0.49) EGFRHDAC3HDAC4HDAC1HDAC7
Hydrochloric Acid SCHEMBL8305108 0.84 EGFR (0.48) EGFRHDAC3HDAC4HDAC1HDAC7
SCHEMBL8308906 0.83 EGFR (0.46) EGFRERBB2GCKRIPK2
SCHEMBL8811481 0.79 HDAC3 (0.46) EGFRFBP1HDAC3HDAC4HDAC1
SCHEMBL5567997 0.79 EGFR (0.48) EGFRERBB2GCK
SCHEMBL8616210 0.77 KDR (0.42) EGFRHDAC3HDAC4HDAC1HDAC7
Hydrochloric Acid SCHEMBL8310540 0.74 EGFR (0.50) EGFRHDAC3HDAC4HDAC1HDAC7
SCHEMBL8615673 0.72 BRAF (0.41) GCK
SCHEMBL8308341 0.72 IGF1R (0.50) EGFRRIPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0790986-B1 ANILINE DERIVATIVES ZENECA LTD (GB) 1999-01-20 EP disclosed
US-5821246-A USEFUL AS TYROSINE KINASE INHIBITORS AND FOR THE TREATMENT OF PROLIFERATIVE DISEASES SUCH AS CANCER ZENECA LIMITED (GB) 1998-10-13 US disclosed
EP-0790986-A1 ANILINE DERIVATIVES ZENECA LIMITED (GB) 1997-08-27 EP disclosed
WO-1996015118-A1 ANILINE DERIVATIVES ZENECA LIMITED (GB) 1996-05-23 WO disclosed